We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

106 hedge funds and large institutions have $52.4M invested in Vaxart in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

446% more capital invested

Capital invested by funds: $9.59M → $52.4M (+$42.8M)

355% more call options, than puts

Call options by funds: $273K | Put options by funds: $60K

222% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 9

24% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 21

22% more funds holding

Funds holding: 87106 (+19)

12.19% more ownership

Funds ownership: 10.98%23.17% (+12%)

Holders
106
Holders Change
+19
Holders Change %
+21.84%
% of All Funds
1.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
26
Reduced
21
Closed
9
Calls
$273K
Puts
$60K
Net Calls
+$213K
Net Calls Change
+$71K

VXRT Hedge Fund Activity: Q1 2024 in Review

106 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2024, worth a combined $52.4M — up 446% from $9.59M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new VXRT positions and 9 closed out — a net gain of 20 holders — while 26 added to existing stakes and 21 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $16.1M. The largest seller was Morgan Stanley, cutting an estimated $484K.

  • 106 institutional investors held Vaxart (VXRT) as of Q1 2024, up from 87 in Q4 2023.
  • Funds reported $52.4M of Vaxart stock for Q1 2024, up 446% quarter-over-quarter.
  • 29 funds opened new Vaxart positions in Q1 2024 and 9 closed out, a net change of +20 holders.
  • The largest Vaxart buyer in Q1 2024 was RA Capital Management, an estimated $16.1M added.
  • The largest Vaxart seller in Q1 2024 was Morgan Stanley, an estimated $484K sold.

Based on aggregated 13F filings for Q1 2024.